Dave Grayzel joined Atlas in 2010 and is managing director of Atlas Venture Development Corp. Having trained at Harvard Medical School and Mass General Hospital, he left academic medicine for biotech over ten years ago and never looked back. Most recently he was head of clinical development and medical affairs at Infinity Pharmaceuticals.
